The Osteosarcoma Institute

In honor of Willie Tichenor’s birthday, make a donation to OSI. 100% of proceeds go directly toward osteosarcoma research and advocacy, which is “What Willie Would Want.” Donate today: osinst.org/donate

Clinical trials move new osteosarcoma treatments from research to real life. From trial phases to benefits and risks, UT MD Anderson Cancer Center’s Dr. J. Andrew Livingston shares what families should know and the questions to ask. Read more: osinst.org/blog/what-are-…

May is #CancerResearchMonth, and OSI is proud to recognize and support the dedicated researchers who are working to improve osteosarcoma treatments. Read the latest on osteosarcoma research here: osinst.org/blog/category/…

May is #CancerResearchMonth, and OSI is proud to recognize and support the dedicated researchers who are working to improve osteosarcoma treatments. Read the latest on osteosarcoma research here: osinst.org/blog/category/…

The same healing process that repairs normal tissue also enables tumors to grow. Today, researchers are working to illuminate elements of cancer metastasis to find a cure for osteosarcoma. Read on: osinst.org/blog/tumor-mic…

This year, Evan is celebrating 20 years of being cancer free after battling osteosarcoma as a teenager. Read his inspiring story and more: osinst.org/blog/a-triathl…

Thursday, we were joined by Philippos Costa, MD on OsteoBites to dicuss, "Zanzalintinib in Osteosarcoma: Balancing Disease Control and Quality of Life". Watch the full episode here: youtube.com/watch?v=TAZpZ3… #MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast

Looking to make a difference? Start a Facebook fundraiser with OSI in minutes and raise money for osteosarcoma research and advocacy today. Learn more here: #fundraise-online" target="_blank" rel="nofollow noopener">osinst.org/ways-to-help/#…

We are pleased to announce the 2026 recipients of the AACR Scientific Achievement Awards. We look forward to celebrating their impactful contributions to cancer research at the AACR Annual Meeting. brnw.ch/21x1uIG #AACR26

Congratulations to OSI-funded researcher Dr. David Lyden on receiving the @AACR Princess Takamatsu Memorial Lectureship. This recognition reflects the significance of his work in cancer metastasis and its potential to inform new approaches to treatment. pediatrics.weill.cornell.edu/news/dr-david-…

The Osteosarcoma Institute and the FDA brought together 370+ researchers, clinicians, and industry leaders to tackle barriers in osteosarcoma drug development. This collaboration is helping build smarter paths to new treatments. Read more: osinst.org/blog/2025-fda-…

The OSI Strategic Advisory Board met last month to refresh OSI’s Scientific Strategic Plan and build consensus around new strategic initiatives to accelerate progress in osteosarcoma. Learn more about the SAB here: osinst.org/blog/advancing…

Osteosarcoma is a rare disease which makes research and funding for drug development difficult. Learn about the four biggest challenges facing osteosarcoma drug development and how OSI is helping to break down these barriers: osinst.org/blog/drug-chal…

Through strategic funding, targeted research priorities, and high-impact partnerships, OSI is advancing osteosarcoma research in hopes of finding better treatments for patients and, ultimately, a cure. Learn more: osinst.org/blog/momentum-…

Meet OSI’s incoming Executive Director, Alli Murdoff. Alli is expanding her long-standing relationship with OSI into a new, full time Executive Director position beginning April 1. Learn more about Alli and the OSI team: #team" target="_blank" rel="nofollow noopener">osinst.org/about/#team.

OSI is pleased to share a recently published perspective paper highlighting considerations for designing clinical trials for patients with relapsed and refractory osteosarcoma. Read the brief online here: doi.org/10.1158/1078-0…

@mat__nova @spike_0124 This is a beautiful tribute to your friend Scott. Thank you for sharing 💛💛💛

hello tezos folks, how do you deal with grief? @spike_0124 and i made an artwork collab about it "i never forgot your empathy" is a tribute to scott's friend, matthew cook, who passed away from osteosarcoma grief can take time to express and can take many forms like art 🙏

Immunotherapy is effective against many cancers but hasn’t been successful in treating osteosarcoma. Two promising areas of study are CAR T cell and natural killer cell therapy. Learn more: osinst.org/blog/immunothe…

BREAKING: Jayden Bailey, a 17-year-old student athlete at Lebanon High School, died after being diagnosed with osteosarcoma, a bone cancer, several years ago. Bailey, a 6-foot-6 junior power forward, was diagnosed with the type of bone cancer in June 2022. His left arm was amputated as a result of the cancer in August 2025. After doctors thought he was cancer-free, the disease spread to his stomach in October 2025. Still, he kept playing basketball and attending classes while inspiring those not only at Lebanon High, but the Tennessee high school basketball community. Bailey was honored by the Lebanon City Council days prior to his death with a proclamation of “Jayden Bailey Day.” He was eventually forced to stop playing and going to school because his body was breaking down, his basketball coach, Jim McDowell said. R.I.P. Jayden Bailey ❤️🙏